- Published on
Diagnostic Tests: Right Upper Quadrant (RUQ) Ultrasound
Clinical Scenarios Where RUQ Ultrasound Is the Correct Answer
A right upper quadrant ultrasound is the first-line imaging test when a patient presents with right upper quadrant abdominal pain, with or without fever. It is specifically designed to evaluate the hepatobiliary system and is highly effective for identifying both liver and biliary tract pathology. RUQ ultrasound is appropriate when assessing:
Most Accurate Diagnostic Tests
While RUQ ultrasound is the best initial test, the most accurate diagnostic tests depend on the suspected pathology:
Significance of Pain During RUQ Ultrasound
If the patient experiences marked tenderness when the ultrasound transducer presses over the gallbladder, this finding is known as a positive Murphy’s sign. A sonographic Murphy’s sign is highly suggestive of acute cholecystitis, especially when accompanied by gallstones, gallbladder wall thickening, or pericholecystic fluid on ultrasound.
Clinical Scenarios Where RUQ Ultrasound Is the Correct Answer
A right upper quadrant ultrasound is the first-line imaging test when a patient presents with right upper quadrant abdominal pain, with or without fever. It is specifically designed to evaluate the hepatobiliary system and is highly effective for identifying both liver and biliary tract pathology. RUQ ultrasound is appropriate when assessing:
- Liver pathology, including:
- Hepatic masses (tumors, abscesses, cysts)
- Evidence of portal hypertension
- Gallbladder and biliary tree disorders, such as:
- Cholelithiasis
- Acute or chronic cholecystitis
- Choledocholithiasis
- Cholangitis
Most Accurate Diagnostic Tests
While RUQ ultrasound is the best initial test, the most accurate diagnostic tests depend on the suspected pathology:
- Biliary pathology (stones, obstruction, cholangitis):
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- MRCP (Magnetic Resonance Cholangiopancreatography)
- Liver pathology (tumors, diffuse liver disease):
- Liver biopsy is the most accurate test
Significance of Pain During RUQ Ultrasound
If the patient experiences marked tenderness when the ultrasound transducer presses over the gallbladder, this finding is known as a positive Murphy’s sign. A sonographic Murphy’s sign is highly suggestive of acute cholecystitis, especially when accompanied by gallstones, gallbladder wall thickening, or pericholecystic fluid on ultrasound.
- Published on
Diagnostic Tests: Pelvic Ultrasound and Transvaginal Ultrasound
When Pelvic Ultrasound Is the Correct Answer
Pelvic ultrasound is indicated when evaluating gynecologic and early pregnancy–related conditions, particularly in emergency and surgical settings. You should answer pelvic ultrasound in clinical scenarios that include:
Pelvic ultrasound is often the first-line imaging study in reproductive-age women presenting with abdominal or pelvic complaints because it is noninvasive, fast, and does not use ionizing radiation.
When Transvaginal Ultrasound Is Preferred
Transvaginal ultrasound (TVUS) provides superior resolution of pelvic structures compared to transabdominal (transpelvic) ultrasound and is preferred in specific situations, including:
Because the transducer is closer to the uterus and adnexa, transvaginal ultrasound offers greater anatomic detail and improved diagnostic accuracy in early pregnancy and pelvic pathology.
When Pelvic Ultrasound Is the Correct Answer
Pelvic ultrasound is indicated when evaluating gynecologic and early pregnancy–related conditions, particularly in emergency and surgical settings. You should answer pelvic ultrasound in clinical scenarios that include:
- Pelvic or lower abdominal pain associated with:
- Amenorrhea
- Vaginal bleeding
- Suspected pregnancy, especially when pregnancy status is unknown
- Suspected ectopic pregnancy, where rapid assessment of the uterus and adnexa is critical
Pelvic ultrasound is often the first-line imaging study in reproductive-age women presenting with abdominal or pelvic complaints because it is noninvasive, fast, and does not use ionizing radiation.
When Transvaginal Ultrasound Is Preferred
Transvaginal ultrasound (TVUS) provides superior resolution of pelvic structures compared to transabdominal (transpelvic) ultrasound and is preferred in specific situations, including:
- Placenta previa, classically presenting as painless vaginal bleeding in the third trimester
- First-trimester pregnancy evaluation, including:
- Confirmation of intrauterine pregnancy
- Early fetal monitoring
- Obese patients, in whom transabdominal imaging may be limited due to poor visualization
Because the transducer is closer to the uterus and adnexa, transvaginal ultrasound offers greater anatomic detail and improved diagnostic accuracy in early pregnancy and pelvic pathology.
- Published on
Diagnostic Tests: Intravenous Pyelogram (IVP)
Overview — Clinical Context for IVP
An intravenous pyelogram (IVP) is a historical imaging test that involved injecting intravenous contrast followed by a series of X-rays to visualize the renal collecting system, including the calyces, renal pelvis, and ureters. Although it was once used to evaluate renal colic, especially when no stones were visible on plain radiographs, IVP has little to no role in modern clinical practice and is almost always an incorrect answer on exams.
Because the test is slow, requires contrast, and provides limited information compared with modern imaging, it has largely been abandoned.
Most Accurate and Preferred Tests Today
IVP has been replaced by safer and more effective imaging modalities:
Because IVP uses contrast, it carries risks of contrast-induced nephropathy and allergic reactions, making it inferior to CT and ultrasound.
Key Exam Pearl
If ultrasound or CT scan appears as an answer choice, IVP is never the correct answer. On exams, IVP is typically included as a distractor rather than the best diagnostic option.
Overview — Clinical Context for IVP
An intravenous pyelogram (IVP) is a historical imaging test that involved injecting intravenous contrast followed by a series of X-rays to visualize the renal collecting system, including the calyces, renal pelvis, and ureters. Although it was once used to evaluate renal colic, especially when no stones were visible on plain radiographs, IVP has little to no role in modern clinical practice and is almost always an incorrect answer on exams.
Because the test is slow, requires contrast, and provides limited information compared with modern imaging, it has largely been abandoned.
Most Accurate and Preferred Tests Today
IVP has been replaced by safer and more effective imaging modalities:
- Renal ultrasound
- Best initial test for suspected renal colic
- No radiation or contrast
- Especially useful in pregnancy or patients with renal insufficiency
- Non-contrast CT scan of the abdomen and pelvis
- Most accurate test for detecting kidney stones
- Fast, highly sensitive and specific
- Does not require contrast when evaluating for stones
Because IVP uses contrast, it carries risks of contrast-induced nephropathy and allergic reactions, making it inferior to CT and ultrasound.
Key Exam Pearl
If ultrasound or CT scan appears as an answer choice, IVP is never the correct answer. On exams, IVP is typically included as a distractor rather than the best diagnostic option.
- Published on
Diagnostic Tests: Oxalate Crystals in Ethylene Glycol Poisoning
Overview — What These Are
The crystals shown are envelope-shaped calcium oxalate crystals, which appear in the urine after ingestion of ethylene glycol, a toxic alcohol found in antifreeze. When ethylene glycol is metabolized, one of its byproducts is oxalic acid, which binds calcium to form calcium oxalate crystals. These crystals can precipitate in the renal tubules, leading to obstruction, inflammation, and ultimately acute tubular necrosis (ATN). Their presence in a patient with metabolic acidosis strongly suggests ethylene glycol poisoning.
Most Accurate Diagnostic Test
The most accurate and definitive test for diagnosing ethylene glycol intoxication is the serum ethylene glycol level.
Other supportive findings include:
- Urinary fluorescence under a Wood’s lamp (can be transient and unreliable)
- Hypocalcemia, because oxalic acid binds serum calcium
- Calcium oxalate crystals on urinalysis
However, a measured blood ethylene glycol level is the gold standard for diagnosis.
When This Is the Correct Answer
Think of ethylene glycol overdose when a case presents with:
- High anion gap metabolic acidosis
- Altered mental status, often in the context of a suicide attempt or accidental ingestion
- Hypocalcemia, which may produce QT prolongation or arrhythmias
- Acute renal failure due to tubular deposition of oxalate crystals
- Calcium oxalate crystals in the urine (classic finding)
Patients often present after ingesting antifreeze, which is sweet-tasting, making it a common agent in intentional or accidental toxic ingestion. The metabolic acidosis is often severe, and kidney injury progresses rapidly without treatment.
- Published on
Diagnostic Tests: Burr Cells
Overview — What Burr Cells Are
Burr cells, also known as echinocytes, are red blood cells that display numerous short, blunt, and regularly spaced spicules on their surface. Their uniform projections give them a spiky appearance, but unlike spur cells, these projections are consistent and evenly distributed. Burr cells typically reflect alterations in the red cell membrane caused by metabolic abnormalities.
Conditions Associated With Burr Cells
Burr cells appear most commonly in systemic diseases that affect the biochemical environment or membrane composition of red blood cells. They are classically associated with:
While some burr cells may arise from artifact during slide preparation, their presence in an appropriate clinical scenario strongly supports renal or hepatic pathology.
Differentiating Burr Cells From Spur Cells
It is important to distinguish burr cells (echinocytes) from spur cells (acanthocytes) because they indicate different underlying conditions.
Overview — What Burr Cells Are
Burr cells, also known as echinocytes, are red blood cells that display numerous short, blunt, and regularly spaced spicules on their surface. Their uniform projections give them a spiky appearance, but unlike spur cells, these projections are consistent and evenly distributed. Burr cells typically reflect alterations in the red cell membrane caused by metabolic abnormalities.
Conditions Associated With Burr Cells
Burr cells appear most commonly in systemic diseases that affect the biochemical environment or membrane composition of red blood cells. They are classically associated with:
- End-stage renal disease (ESRD)
Uremic toxins disrupt red cell membranes, producing echinocyte formation. - Liver disease
Changes in plasma lipid composition and membrane stability can lead to burr cell development.
While some burr cells may arise from artifact during slide preparation, their presence in an appropriate clinical scenario strongly supports renal or hepatic pathology.
Differentiating Burr Cells From Spur Cells
It is important to distinguish burr cells (echinocytes) from spur cells (acanthocytes) because they indicate different underlying conditions.
- Burr cells (echinocytes):
- Many short, uniform, regularly spaced spicules
- Associated with ESRD and liver disease
- Spur cells (acanthocytes):
- Few, irregular, unevenly spaced spicules
- Seen in severe liver disease, some hereditary spherocytosis, and myelodysplastic syndromes
- Published on
Diagnostic Tests: Decay-Accelerating Factor (DAF) / CD55–CD59 Assay
Overview
The CD55/CD59 assay—also known as the decay-accelerating factor (DAF) assay—is a laboratory test used to evaluate the presence of GPI-anchored protective proteins on the surface of red blood cells. In paroxysmal nocturnal hemoglobinuria (PNH), a mutation in the PIGA gene prevents the attachment of these proteins, particularly CD55 and CD59, leaving RBCs vulnerable to complement-mediated lysis. Measuring the presence or absence of CD55/CD59 via flow cytometry allows clinicians to directly identify PNH cells.
When This Is the Most Accurate Diagnostic Test
The CD55/CD59 flow cytometry assay is the most accurate and definitive test for diagnosing paroxysmal nocturnal hemoglobinuria. Unlike older screening tests such as the sucrose lysis test or Ham’s test, flow cytometry precisely quantifies the proportion of blood cells lacking complement-regulating proteins. Because it identifies the exact molecular defect, it remains the gold standard for diagnosing PNH.
When to Choose DAF (CD55/CD59) as the Correct Answer
You should select the CD55/CD59 assay when a clinical presentation strongly suggests PNH, especially in cases involving:
Whenever these features cluster together, particularly dark morning urine and thrombosis, the DAF (CD55/CD59) assay is the diagnostic test of choice.
Overview
The CD55/CD59 assay—also known as the decay-accelerating factor (DAF) assay—is a laboratory test used to evaluate the presence of GPI-anchored protective proteins on the surface of red blood cells. In paroxysmal nocturnal hemoglobinuria (PNH), a mutation in the PIGA gene prevents the attachment of these proteins, particularly CD55 and CD59, leaving RBCs vulnerable to complement-mediated lysis. Measuring the presence or absence of CD55/CD59 via flow cytometry allows clinicians to directly identify PNH cells.
When This Is the Most Accurate Diagnostic Test
The CD55/CD59 flow cytometry assay is the most accurate and definitive test for diagnosing paroxysmal nocturnal hemoglobinuria. Unlike older screening tests such as the sucrose lysis test or Ham’s test, flow cytometry precisely quantifies the proportion of blood cells lacking complement-regulating proteins. Because it identifies the exact molecular defect, it remains the gold standard for diagnosing PNH.
When to Choose DAF (CD55/CD59) as the Correct Answer
You should select the CD55/CD59 assay when a clinical presentation strongly suggests PNH, especially in cases involving:
- Intermittent dark urine, often most noticeable in the morning due to overnight complement activation
- Pancytopenia, reflecting bone marrow failure that often accompanies PNH
- Unexplained large-vessel thrombosis, particularly in unusual locations such as hepatic, portal, or cerebral veins
- Hemolysis with a negative Coombs test, consistent with complement-mediated destruction rather than autoimmune hemolysis
Whenever these features cluster together, particularly dark morning urine and thrombosis, the DAF (CD55/CD59) assay is the diagnostic test of choice.
- Published on
Diagnostic Tests: Cold Agglutinins
Overview
Cold agglutinins are IgM autoantibodies directed against antigens on red blood cells. These antibodies become active at lower temperatures, typically between 0–4°C, causing RBCs to clump (agglutinate) and leading to complement-mediated hemolysis. Measurement of cold agglutinin titers is used when cold agglutinin disease, a form of autoimmune hemolytic anemia, is suspected. Because IgM is very efficient at fixing complement, even mild cooling of peripheral blood (fingers, toes, ears) can trigger hemolysis in affected individuals.
Associated Diseases
Cold agglutinins are seen in several conditions, including both malignancies and infections:
These disorders trigger the production of IgM antibodies that bind RBCs at lower temperatures, leading to hemolysis.
When to Choose Cold Agglutinins as the Correct Answer
You should select cold agglutinins when a patient presents with:
Important distinction:
Do not confuse cold agglutinins with cryoglobulins.
Overview
Cold agglutinins are IgM autoantibodies directed against antigens on red blood cells. These antibodies become active at lower temperatures, typically between 0–4°C, causing RBCs to clump (agglutinate) and leading to complement-mediated hemolysis. Measurement of cold agglutinin titers is used when cold agglutinin disease, a form of autoimmune hemolytic anemia, is suspected. Because IgM is very efficient at fixing complement, even mild cooling of peripheral blood (fingers, toes, ears) can trigger hemolysis in affected individuals.
Associated Diseases
Cold agglutinins are seen in several conditions, including both malignancies and infections:
- Lymphoid malignancies:
- Lymphoma
- Chronic lymphocytic leukemia (CLL)
- Waldenström macroglobulinemia
- Infectious causes:
- Mycoplasma pneumoniae infection (classic association)
- Infectious mononucleosis (EBV)
These disorders trigger the production of IgM antibodies that bind RBCs at lower temperatures, leading to hemolysis.
When to Choose Cold Agglutinins as the Correct Answer
You should select cold agglutinins when a patient presents with:
- Signs of hemolytic anemia (fatigue, jaundice, dark urine)
- Symptoms worsened by cold exposure, such as:
- Painful, blue or purple discoloration of fingers, toes, ears, or nose
- Livedo reticularis–like changes
- Acrocyanosis
Important distinction:
Do not confuse cold agglutinins with cryoglobulins.
- Cold agglutinins → cause hemolysis and cold-induced skin color changes.
- Cryoglobulins → cause purpuric skin lesions, arthralgias, and glomerulonephritis, not hemolysis.
- Published on
Diagnostic Tests: Water Deprivation Test
Overview — What This Test Is For
The water deprivation test is used to distinguish among the causes of diabetes insipidus (DI) and to assess whether a patient with hypernatremia and high urine output is able to concentrate urine appropriately. It evaluates the kidney’s ability to conserve water when fluid intake is restricted. This helps differentiate central DI, nephrogenic DI, and primary polydipsia.
How the Test Is Performed
During the water deprivation test, all water intake is restricted for 12–24 hours, while the patient is closely monitored. Several parameters are measured:
As serum osmolality rises, healthy kidneys should conserve water, producing small amounts of concentrated urine.
Interpretation:
This sequence allows clinicians to determine both the presence and type of DI.
When the Water Deprivation Test Is the Correct Answer
Choose the water deprivation test as the best initial diagnostic test when the patient presents with:
These findings suggest impaired renal concentration ability consistent with DI. The water deprivation test is the appropriate next step to confirm the diagnosis and differentiate between its central and nephrogenic forms.
Overview — What This Test Is For
The water deprivation test is used to distinguish among the causes of diabetes insipidus (DI) and to assess whether a patient with hypernatremia and high urine output is able to concentrate urine appropriately. It evaluates the kidney’s ability to conserve water when fluid intake is restricted. This helps differentiate central DI, nephrogenic DI, and primary polydipsia.
How the Test Is Performed
During the water deprivation test, all water intake is restricted for 12–24 hours, while the patient is closely monitored. Several parameters are measured:
- Urine volume
- Urine osmolality
- Serum osmolality
- Body weight
As serum osmolality rises, healthy kidneys should conserve water, producing small amounts of concentrated urine.
Interpretation:
- If urine remains dilute despite rising serum osmolality → this indicates diabetes insipidus.
- After this, vasopressin (ADH) is administered:
- Urine concentrates → Central DI (kidneys respond once ADH is provided).
- No change in urine concentration → Nephrogenic DI (kidneys are resistant to ADH).
This sequence allows clinicians to determine both the presence and type of DI.
When the Water Deprivation Test Is the Correct Answer
Choose the water deprivation test as the best initial diagnostic test when the patient presents with:
- Hypernatremia
- Polyuria (high urine output)
- Dilute urine despite elevated serum osmolality
These findings suggest impaired renal concentration ability consistent with DI. The water deprivation test is the appropriate next step to confirm the diagnosis and differentiate between its central and nephrogenic forms.
- Published on
Diagnostic Tests: Coombs’ Agglutinin Test
Overview — What This Test Is
The Coombs’ test, also known as the antiglobulin test, detects antibodies directed against red blood cells. It identifies whether RBCs are coated with immunoglobulin or complement. There are two forms:
- Direct Coombs’ test (DAT): Detects antibodies attached to the patient’s RBCs.
- Indirect Coombs’ test: Detects antibodies circulating in the patient’s serum.
The Direct Coombs’ test is the one used in evaluating hemolysis.
Clinical Significance
The Coombs’ test is central to diagnosing autoimmune hemolytic anemia (AIHA). A positive direct Coombs’ test indicates that red blood cells have been coated with IgG and/or complement, leading to premature destruction. When the patient’s RBCs agglutinate after addition of the Coombs reagent, it confirms immune-mediated hemolysis.
A positive Coombs’ test is also helpful in distinguishing autoimmune hemolysis from non-immune causes such as mechanical destruction or enzymatic defects.
Most Common Cause of a Positive Coombs’ Test
Between 30–50% of Coombs’ positive hemolytic anemia cases are idiopathic, meaning no clear underlying cause can be identified.
Among identifiable causes, the most common are drug-induced hemolysis, especially due to:
- Penicillin
- Quinidine
- Alpha-methyldopa
- Sulfa drugs
- Aspirin
These medications may either cause antibodies to form against RBCs or bind to RBCs themselves, triggering an immune response and hemolysis.
- Published on
Diagnostic Tests: Ristocetin Cofactor Assay
Overview — What This Test Is
The Ristocetin Cofactor Assay is a laboratory test that evaluates the functional activity of von Willebrand factor (VWF).
Ristocetin acts as a surrogate for the endothelial surface, promoting VWF-mediated platelet agglutination. When VWF is present and functioning normally, platelets will clump in response to ristocetin.
This assay, together with a VWF antigen level, is considered one of the most accurate tests for diagnosing von Willebrand disease (vWD).
When This Is the Correct Answer
Choose the Ristocetin Cofactor Assay when a patient presents with:
This pattern suggests qualitative VWF defects, particularly Type 2 von Willebrand disease, where VWF quantity may be normal but function is impaired.
The ristocetin assay detects impaired VWF-mediated platelet adhesion, helping distinguish between quantitative and qualitative defects.
Overview — What This Test Is
The Ristocetin Cofactor Assay is a laboratory test that evaluates the functional activity of von Willebrand factor (VWF).
Ristocetin acts as a surrogate for the endothelial surface, promoting VWF-mediated platelet agglutination. When VWF is present and functioning normally, platelets will clump in response to ristocetin.
This assay, together with a VWF antigen level, is considered one of the most accurate tests for diagnosing von Willebrand disease (vWD).
When This Is the Correct Answer
Choose the Ristocetin Cofactor Assay when a patient presents with:
- Platelet-type bleeding, such as:
- Epistaxis
- Petechiae
- Purpura
- Gum bleeding or gingival bleeding
- Normal platelet count
- Normal VWF level, but clinical suspicion for vWD remains
(e.g., VWF is present but non-functional)
This pattern suggests qualitative VWF defects, particularly Type 2 von Willebrand disease, where VWF quantity may be normal but function is impaired.
The ristocetin assay detects impaired VWF-mediated platelet adhesion, helping distinguish between quantitative and qualitative defects.
